CORC

浏览/检索结果: 共11条,第1-10条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
2,4-Diarylamino-pyrimidines as kinase inhibitors co-targeting IGF1R and EGFR(L858R/T790M) 期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 卷号: 25, 期号: 19, 页码: 4277-4281
作者:  Chan, Shingpan;  Han, Kun;  Qu, Rong;  Tong, Linjiang;  Li, Yingjun
收藏  |  浏览/下载:51/0  |  提交时间:2019/01/08
A randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced mucosal melanoma 会议论文
作者:  Sheng, Xi Nan;  Si, Lu;  Chi, Zhihong;  Cui, Chuanliang;  Li, Si Ming
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/04
Efficacy and safety analysis of trastuzumab and paclitaxel based regimen plus carboplatin or epirubicin as neoadjuvant therapy for clinical stage II-III, HER2-positive breast cancer patients: a phase 2, open-label, multicenter, randomized trial. 期刊论文
Oncotarget, 2015, 卷号: 6, 期号: 21, 页码: 18683-18692
作者:  Huang, Liang;  Chen, Sheng;  Yang, Wentao;  Xu, Binghe;  Huang, Tao
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/03
BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non-Small-Cell Lung Cancer. 期刊论文
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, 卷号: 33, 期号: 19, 页码: 2197-U108
作者:  Zhou, Caicun*;  Wu, Yi-Long;  Chen, Gongyan;  Liu, Xiaoqing;  Zhu, Yunzhong
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/03
Efficacy and safety analysis of trastuzumab and paclitaxel based regimen plus carboplatin or epirubicin as neoadjuvant therapy for clinical stage II-III, HER2-positive breast cancer patients: a phase 2, open-label, multicenter, randomized trial 期刊论文
ONCOTARGET, 2015, 卷号: 6, 期号: 21
作者:  Huang, Liang;  Chen, Sheng;  Yang, Wentao;  Xu, Binghe;  Huang, Tao
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/19
BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non-Small-Cell Lung Cancer 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2015, 卷号: 33, 期号: 19
作者:  Zhou, Caicun;  Wu, Yi-Long;  Chen, Gongyan;  Liu, Xiaoqing;  Zhu, Yunzhong
收藏  |  浏览/下载:1/0  |  提交时间:2019/12/19
Phase II trial of weekly nab-paclitaxel and carboplatin treatment with or without trastuzumab as nonanthracycline neoadjuvant chemotherapy for locally advanced breast cancer 期刊论文
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2015, 卷号: 10
作者:  Huang, Liang;  Chen, Sheng;  Yao, Ling;  Liu, Guangyu;  Wu, Jiong
收藏  |  浏览/下载:1/0  |  提交时间:2019/12/19
Paclitaxel Enhances Carboplatin-DNA Adduct Formation and Cytotoxicity 期刊论文
Chemical Research in Toxicology, 2015, 卷号: 28, 期号: 12
作者:  Jiang, Shuai/53876062700[0];  Pan, Amywang/57016224100[1];  Lin, Tzuyin/56979710700[2];  Zhang, Hongyong/36699081500[3];  Malfatti, Michael A./6602635370[4]
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/19
Corilagin, an anti-tumor herb medicine, sensitizes paclitaxel and carboplatin by primarily inhibiting glycolysis pathways in epithelial ovarian cancer 会议论文
作者:  Jia, Luoqi;  Jin, Hongyan;  Lv, Minzhi;  Zhao, Naiqing;  Liu, Shaosong
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/19
Efficacy and safety analysis of trastuzumab and paclitaxel based regimen plus carboplatin or epirubicin as neoadjuvant therapy for clinical stage II-III, HER2-positive breast cancer patients: a phase 2, open-label, multicenter, randomized trial 期刊论文
2015, 卷号: 6, 期号: 21, 页码: 18683-18692
作者:  Huang, Liang;  Chen, Sheng;  Yang, Wentao;  Xu, Binghe;  Huang, Tao
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/13


©版权所有 ©2017 CSpace - Powered by CSpace